Juan Vicente-Valor

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Benign Prostatic Hyperplasia

Cardiovascular Risk Factors

Tyrosine Kinase

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Pharmacological reports : PR

This page only lists publications with an associated author ORCID identifier.

Publications

Sofía Tesolato, Juan Vicente-Valor, Mateo Paz-Cabezas, Maria Dulcenombre Gómez-Garré, Silvia Sánchez-González, Adriana Ortega-Hernandez, Sofía Cristina de la Serna, Inmaculada Domínguez-Serrano, Jana Dziakova, Daniel Rivera, Jose-Ramón Jarabo, Ana-María Gómez-Martínez, Florentino Hernando, Antonio Torres, Pilar Iniesta
Gut Microbiota Signatures with Potential Clinical Usefulness in Colorectal and Non-Small Cell Lung Cancers. Biomedicines 12 (3) (2024)
Sofía Tesolato, Juan Vicente-Valor, Mateo Paz-Cabezas, Maria Dulcenombre Gómez-Garré, Silvia Sánchez-González, Adriana Ortega-Hernandez, Sofía Cristina de la Serna, Inmaculada Domínguez-Serrano, Jana Dziakova, Daniel Rivera, Jose-Ramón Jarabo, Ana-María Gómez-Martínez, Florentino Hernando, Antonio Torres, Pilar Iniesta
Gut Microbiota Signatures with Potential Clinical Usefulness in Colorectal and Non-Small Cell Lung Cancers. Biomedicines 12 (3) (2024)
Juan Vicente-Valor, Carmen Rodríguez-González, María Ferris-Villanueva, Esther Chamorro-de-Vega, Rosa Romero-Jiménez, Daniel Gómez-Costas, Sergio Herrero-Bermejo, Francisco Tejerina-Picado, Santiago Osorio-Prendes, Gillen Oarbeascoa-Royuela, Ana Herranz-Alonso, María Sanjurjo-Sáez
Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study. Pharmacological reports : PR (2023)
Juan Vicente-Valor, Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Cristina López-López, Cristina Villanueva-Bueno, José Luis Revuelta-Herrero, Paula Ruiz-Briones, Beatriz Somoza-Fernández, Ana Herranz, María Sanjurjo
Potential negative pharmacodynamic interaction of spironolactone and abiraterone in two prostate cancer patients. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Paula Ruiz-Briones, Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Juan Vicente-Valor, Rosa Alvarez, Cristina Villanueva-Bueno, Álvaro Narrillos-Moraza, Ana Herranz, Maria Sanjurjo
Possible heart failure caused by osimertinib in a lung cancer patient. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)